About Feldan Therapeutics
Creating better futures for patients, Feldan drives deep science and therapeutic innovation by enabling the intracellular delivery of ASO.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
feldan.com
Domain Registered Date
Nov 19, 2005
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
startupintros.com
- Capital Raise
Raised $16,500,000 · Series-B+
startupintros.com
- Capital Raise
Raised $12,500,000 · Series-A
startupintros.com
- Milestone
Website domain registered
feldan.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Feldan Therapeutics.
Funding History
Series-B+
· Sep 4, 2024
Undisclosed startupintros.com
Series-B+
· Jun 13, 2023
$16,500,000 startupintros.com
Series-A
· Sep 18, 2018
$12,500,000 startupintros.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026